BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
13 results:

  • 1. Automated Feeder-Detection Software for Renal Cell Carcinoma Embolization: A Retrospective Evaluation of Detection Rate Using Transarterial Time-Resolved Computed Tomography Angiography.
    Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Munetomo K; Nagata S; Kurozumi A; Ujifuku A; Iguchi T; Hiraki T
    Cardiovasc Intervent Radiol; 2024 Jan; 47(1):132-138. PubMed ID: 38010507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Head-to-head comparison of [
    Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Localized cystic disease of the kidney in pediatric patients: Clinical and imaging findings with long term follow up.
    Yoon H; Kim MJ; Shin HJ; Lee MJ
    J Pediatr Urol; 2022 Feb; 18(1):90.e1-90.e8. PubMed ID: 34862129
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients.
    Mund E; Salem J; Kreipe HH; Hussein K
    J Clin Pathol; 2022 Feb; 75(2):112-116. PubMed ID: 33372107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by evi1 in AML.
    Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
    PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
    Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
    Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Frequency of associated malignancies in cutaneous lymphomas: a retrospective study of 86 cases].
    Wejroch MP; Cornillet P; Perceau G; Durlach A; Bernard P
    Ann Dermatol Venereol; 2004 Apr; 131(4):339-45. PubMed ID: 15258507
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    Mod Pathol; 2004 Feb; 17(2):180-8. PubMed ID: 14657952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
    Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ
    Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
    Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
    Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.
    Risin D; Kleinerman ES; Umezu Y; Pizzini RP; Balch CM; Pellis NR
    Cancer Immunol Immunother; 1995 Jan; 40(1):57-64. PubMed ID: 7828168
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.